Perioperative Opioid Exposure Patterns in Pediatric Anterior Cruciate Ligament Reconstruction: A Ten-Year

Dharman Anandarajan1, Brendan A Williams1, Nathan D Markiewitz1

  • 1Division of Orthopaedics, Children's Hospital of Philadelphia, Philadelphia, USA.

Cureus
|April 19, 2021
PubMed

Insights

Perioperative opioid exposure in pediatric anterior cruciate ligament reconstruction is common, affecting 88% of patients. Factors like age, gender, insurance, and hospital setting influence exposure, which has not declined and varies significantly between facilities.

Area of Science:

  • Pediatric Orthopedics
  • Pain Management
  • Health Services Research

Background:

  • Perioperative opioid exposure is a growing concern in pediatric surgery.
  • Limited data exists on national trends in opioid use for pediatric anterior cruciate ligament reconstruction.
  • Understanding demographic and hospital-level factors influencing exposure is crucial.

Purpose of the Study:

  • To analyze national trends in perioperative opioid exposure for pediatric anterior cruciate ligament reconstruction.
  • To identify demographic factors associated with opioid administration and exposure levels.
  • To assess hospital-level variations in opioid utilization.

Main Methods:

  • Utilized the Pediatric Health Information Systems Database (PHIS) from 2008-2017.
  • Included 19,821 pediatric patients (≤ 18 years) undergoing anterior cruciate ligament reconstruction.
  • Employed a hurdle generalized additive model to analyze opioid administration and relative opioid exposure (ROE).

Main Results:

  • 88% of patients received perioperative opioids, with no significant temporal trend observed.
  • Inpatient or observation settings, and female gender were associated with lower opioid administration likelihood.
  • Commercial insurance correlated with higher relative opioid exposure; age and hospital trends were predictive.

Conclusions:

  • Demographics (gender, age), surgical setting, hospital type, and insurance status significantly predict perioperative opioid exposure in pediatric ACL reconstruction.
  • Opioid exposure rates have remained stable and show considerable inter-hospital variability.
  • Further research is needed to explore the drivers of this variability and optimize opioid utilization.
Abstract

Related Concept Videos

Opioid Analgesics: Synthetic and Semisynthetic Opioids01:15

Opioid Analgesics: Synthetic and Semisynthetic Opioids

Synthetic and semisynthetic opioids are pivotal in pain management and tackling opioid addiction. Semisynthetic opioids, including morphinans (morphine derivatives), oxycodone, oxymorphone, hydrocodone, and hydromorphone, have improved pharmacokinetic profiles compared to morphine. Additionally, heroin and 6-MAM (6-Monoacetylmorphine) show better CNS penetration than morphine due to heightened lipid solubility. Hydromorphone, a potent opioid, undergoes hepatic metabolism to form the active...
621
Local Anesthetics: Clinical Application as Epidural Anesthesia01:29

Local Anesthetics: Clinical Application as Epidural Anesthesia

Epidural anesthetics are administered in the fat-filled epidural space, the outermost part of the spinal canal. This technique is commonly employed for pain management and anesthesia during lower abdomen and pelvis surgeries or labor and delivery.
Since epidural anesthetics can be infused through an epidural catheter, all types of drugs, including short-acting ones, can be administered. Chloroprocaine and lidocaine are examples of short and long-duration anesthetics, respectively. Bupivacaine...
571
Analgesia and Pain Management01:25

Analgesia and Pain Management

Pain is critical to various clinical pathologies, provoking an urgent need for effective management. Pain, whether acute or chronic, is a complex neurochemical process. Its alleviation depends on the type, with nonopioid analgesics effective for mild to moderate pain, such as musculoskeletal or inflammatory pain, while neuropathic pain responds best to anticonvulsants, tricyclic antidepressants, or serotonin/norepinephrine reuptake inhibitors. For severe acute or chronic pain, opioids may be...
1.1K